ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

ÑîÑï¡¢¡¢ÕÅç÷ºÍ³ÂÎĽÝÍŶÓʹÓÃÐÂÐÍË®Äý½ºÁªºÏÃâÒßϸ°û½â¾ö¸Î°©Õ­ÇÐÔµÊõºóÖ×Áö¸´¾ÙÊÂÌâ

¸å¼þȪԴ£º£º£ºÁ¥ÊôµÚÈýÒ½Ôº ±à¼­£º£º£ºÀîͯÖÛ¡¢¡¢Íõ¶¬Ã· ÉóºË£º£º£ºÏÄçø ÔĶÁÁ¿£º£º£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±¹¨Ò»º½£©¿ËÈÕ£¬£¬ngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½Ôº¸ÎÔàÍâ¿ÆÑîÑï½ÌÊÚÍŶӺÍÉúÎïÖÎÁÆÖÐÐÄÕÅç÷½ÌÊÚ¡¢¡¢³ÂÎĽݽÌÊÚÍŶÓÏàÖúÔÚÖпÆÔºÒ»ÇøÆÚ¿¯Biomaterials£¨IF=15.304£©½ÒÏþÁËÌâΪ¡°Injectable adhesive hemostatic gel with tumor acidity neutralizer and neutrophil extracellular traps lyase for enhancing adoptive NK cell therapy prevents post-resection recurrence of hepatocellular carcinoma¡±µÄ×îÐÂѧÊõЧ¹û¡£¡£¸ÃÑо¿½«ÉúÎïÖÊÁÏѧÓëҽѧÏàÁ¬Ïµ£¬£¬½«ÐÂÑз¢µÄÉúÎï¾ÛºÏË®Äý½ºÕ³¸½Ôڸΰ©Õ­ÇÐÔµÊõºóµÄÔàÆ÷¶ÏÃæ£¬£¬¿É¸ÄÉÆÖ×ÁöËá¶È¼°½µ½âÖÐÐÔÁ£Ï¸°ûÍâ²¶»ñÍø£¨NETs£©£¬£¬½ø¶øÔöÃôNKϸ°û¹ý¼ÌÖÎÁƵÄÁÆÐ§£¬£¬×îÖÕ·ÀÖ¹Õ­ÇÐÔµÊõºóµÄÖ×Áö¸´·¢¡£¡£ÕâÊÇNKϸ°û»ù´¡Ñо¿ÏòÁÙ´²×ª»¯µÄÓÖÒ»Á¢ÒìÐÔЧ¹û¡£¡£

Íâ¿ÆÊÖÊõÇгýÊÇÏÖÔÚÓ¦¶Ô¸Î°©×îÓÐÓᢡ¢Ó¦ÓÃ×îÆÕ±éµÄÖÎÁÆ·½Ê½¡£¡£È»¶ø£¬£¬Ñо¿·¢Ã÷Êõºó5ÄêµÄÖ×Áö¸´·¢Âʸߴï50%¡«70%£¬£¬ÊõÖгöѪºÍÕ­ÇÐÔµÊǵ¼Ö¸ΰ©Çгýºó¸´·¢µÄÖ÷ҪΣÏÕÒòËØ¡£¡£Òò´Ë£¬£¬ÊõÖгöѪ¼°ÇÐÔµ¹ýÕ­¶¼ÊÇÔ¤·À¸Î°©¸´·¢Ø½´ý½â¾öµÄÁÙ´²ÎÊÌâ¡£¡£NKϸ°û¹ý¼Ì±»ÒÔΪÊÇÒ»ÖÖºÜÓÐǰ;µÄÖ×ÁöÃâÒßÖÎÁÆ£¬£¬È»¶ø£¬£¬ËáÐÔÖ×Áö΢ÇéÐΣ¨TME£©¡¢¡¢ÖÐÐÔÁ£Ï¸°ûÍâ²¶»ñÍø£¨NETs£©ÒÔ¼°ÃâÒßÒÖÖÆµÈÖØ´ó»úÖÆÑÏÖØÓ°ÏìÁËÆäÁÆÐ§¡£¡£Îª´Ë£¬£¬ÍŶÓÑÐÖÆÁËÒ»ÖÖº¬ÓÐÖ×ÁöËá¶ÈÖкͼÁºÍNETsÁѽâø£¨DNaseI£©µÄË«pHÏìӦˮÄý½º£¬£¬²¢ÓëNKϸ°û¹ý¼ÌÁÆ·¨ÁªºÏÓ¦ÓÃÒÔÔ¤·À¸Î°©Õ­ÇÐÔµÊõºó¸´·¢¡£¡£¸ÃË®Äý½º¿ÉÅçÍ¿µ½ÊÖÊõÇÐÔµ£¬£¬ÐγÉÕ³¸½ÐÔÄý½º£¬£¬Ñ¸ËÙֹѪ¡£¡£±ðµÄ£¬£¬Ëü»¹ÄÜÖкÍÖ×ÁöµÄËáÐÔ΢ÇéÐΣ¬£¬ïÔÌ­ÃâÒßÒÖÖÆÐÔϸ°ûµÄ¾Ö²¿½þÈ󣬣¬ÊÍ·ÅDNaseIÒÔ½µ½âNETs¡£¡£¶¯ÎïʵÑé֤ʵÕâÖÖÁªºÏÁÆ·¨ÏÔÖøÔöÇ¿ÁËNKϸ°û¹ý¼ÌµÄÁÆÐ§£¬£¬ÇÒûÓÐÒýÆðÏÔ×ŵÄÈ«Éí¶¾ÐÔ¡£¡£

ÔÚÑîÑï½ÌÊÚºÍÕÅç÷½ÌÊÚµÄÏòµ¼Ï£¬£¬¸ÎÔàÍâ¿Æô߸ÎÒÆÖ²ÖÐÐÄÓëÉúÎïÖÎÁÆÖÐÐÄϸÃÜЭ×÷£¬£¬ÔÚ¹ú¼ÊÉÏÂÊÏȽ«NKϸ°ûÓÃÓÚ¸ÎÔàÒÆÖ²ºóµÄ¸Î°©¸´·¢ÖÎÁÆ£¬£¬Ö¤ÊµNKϸ°ûÖÎÁƾßÓнϺõÄÇå¾²ÐÔ£¬£¬¸ÄÉÆÁË»¼ÕßÔ¤ºó£¬£¬Îª½â¾ö¸ÎÒÆÖ²ºó¸Î°©¸´·¢µÄÄÑÌâÌṩÁËÐÂ˼Ð÷¡£¡£¸ÃÑо¿µÄÁ¢ÒìµãÔÚÓÚ£¬£¬ÔÚº£ÄÚÍâÂÊÏÈÌá³öÁ˽«ÉúÎï¾ÛºÏË®Äý½ºÁªºÏÃâÒßϸ°ûÖÎÁÆÓÃÓÚ½â¾ö¸Î°©Õ­ÇÐÔµÊõºó¸´·¢µÄÁÙ´²ÎÊÌ⣬£¬½øÒ»²½¸»ºñÁ˸ΰ©¸´·¢µÄ¶àѧ¿Æ×ÛºÏÖÎÁÆÕ½ÂÔ¡£¡£Î´À´Ë«·½ÍŶӽ«¼ÌÐøÐ¯ÊÖ½â¾öÁÙ´²ÇÐʵÎÊÌ⣬£¬½øÒ»²½Íƽø¿ÆÑÐЧ¹ûÏòÁÙ´²Ó¦ÓÃת»¯¡£¡£

³ÂÎĽݽÌÊÚ¡¢¡¢ÑîÑï½ÌÊÚºÍÖÜÀÙ½ÌÊÚΪÎÄÕÂÅäºÏͨѶ×÷Õß¡£¡£³ÌԤʤ²©Ê¿ºó¡¢¡¢¹¨Ò»º½²©Ê¿¡¢¡¢³ÂÐãÐDz©Ê¿¡¢¡¢ÕÅÏ£½¡²©Ê¿¡¢¡¢ÕÅç÷½ÌÊÚΪÅäºÏµÚÒ»×÷Õß¡£¡£

ÂÛÎÄÁ´½Ó£º£º£ºhttps://pubmed.ncbi.nlm.nih.gov/35390709/


¡¾ÍøÕ¾µØÍ¼¡¿